GlobalData on MSN
FDA clears Hologic’s Aptima SARS-CoV-2 assay
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Hologic's Aptima SARS-CoV-2 assay, marking an ...
-- Company to Produce at Least One Million Tests a Week to Run on More than 1,000 Panther Instruments Installed in All 50 States -- -- Significant Assay Manufacturing Capacity Plus Large Installed ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Aptima® SARS-CoV-2 assay, ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the FDA has granted clearance for its new Aptima ® BV and Aptima ® CV/TV assays, which provide an accurate and ...
Hologic, Inc, an innovative medical technology company, announced that the US Food and Drug Administration (FDA) has granted clearance for its new Aptima BV and Aptima CV/TV assays, which provide an ...
MARLBOROUGH, Massachusetts, Nov. 15, 2016 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that it has obtained a CE Mark for the Company's Herpes Simplex Virus (HSV) assay, enabling the ...
Hologic, Inc. (Nasdaq: HOLX) announced today that it plans to launch a new Aptima® molecular assay to detect the SARS-CoV-2 virus that will run on its market-leading Panther® system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback